MSDC logo
Home  |  Press Room  |  Join Us  |  Contact Us
     Member Center  |  About MSDC  |  Issues and Advocacy  |  MSDC & the Community  |  News & Events
Welcome to MSDC Commiunity
 
 

Latest News

 

Sexually Transmitted Diseases Treatment Guidelines

The Centers for Disease Control and Prevention's Sexually Transmitted Diseases Treatment Guidelines have been updated.  Click here to access the most current version.

Syphilis on the Rise in DC

At a meeting of hospital medical directors, Dr. B. W. Furness MD, MPH, LCDR, USPHS, CDC STD Control Program made a presentation regarding Syphilis in the District of Columbia.  In summary, he indicated that:

"Primary and secondary syphilis is on the rise in Washington, DC.  In fact, the number of infectious syphilis cases reported in the District increased 168% from 2000 to 2005.  Cases were predominantly reported among men, African Americans, and those 30-39 years of age.  It is a common misconception that syphilis only affects African Americans from Southeast Washington, DC.  In reality, the percentage of cases reported among Blacks has been gradually decreasing while the percentage of cases reported among Whites has been gradually increasing.  In addition, cases are being reported from all over Washington, DC.  In 2000, the greatest number of cases was reported in Ward 8, but in 2005, the greatest number of cases was reported in Ward 2.  The location of diagnosis has also been shifting – in 2000, 32% of infectious syphilis cases were reported from the Southeast STD Clinic while 29% of cases were reported from private MDs and HMOs.  In 2005, only 15% of infectious syphilis cases were reported from the Southeast STD Clinic, 46% of cases were reported from private MDs and HMOs, and 13% of cases were reported from hospitals.  Of note, the number of infectious syphilis cases reported among men who have sex with men (MSM) has also been gradually increasing."

If you would like to view the Power Point slides that accompanied this presentation, click here.

Critical Incident Stress Management Involving Weapons of Mass Destruction Events

This pro-active course presents situations that cause first responders to experience strong emotional reactions as a result of their decisions.  It also presents both short and long term stress reduction techniques that address what the first responder will potentially encounter during a weapons of mass destruction attack. To enroll for the class complete this registration form.  This course takes place on Thursday, March 9,from 9:00 am  to 5:00 pm at the True Auditorium, in the Washington Hospital Center, 111 Irving Street, Washington, DC.  For additional information, please call 202-671-4222 or send an email to ehrcinfo@dc.gov.

Students and Physicians Attend Domestic Abuse Seminar

The first Annual Domestic Violence Training Seminar sponsored by Howard University College of Medicine and the American Medical Student Association was a great success.  The seminar, supported by the MSDC Task Force on Family Violence, was held to inform current and future health care professionals of the detection and treatment of domestic abuse.  The lecture topics covered all aspects of domestic abuse including sexual assault, child abuse, elder abuse and domestic violence and the criminal justice community.  If you would like to learn more about the medical aspects of domestic abuse or related issues, please contact MSDC’s Task Force on Family Violence Chairman Kim Bullock, MD, at 202-269-7996 or kimabullock@hotmail.com

DC Department of Health's SARS Reporting Protocol.

With Severe Acute Respiratory Syndrome (SARS) back in the headlines, the Medical Society wants to make sure its members are aware of the DC Department of Health's SARS Reporting Protocol:

* Hospital or other healthcare facility contacts the Department of Health (DOH) Bureau of Communicable Disease Control (BCDC) at 202-442-9131, 202-442-5842, and/or 202-442-9371 with suspected case information. (After hours and weekend number 202-727-6161),

* BCDC takes case information and consults with Chief of BCDC, Dr. Karyn L. Berry.  If determined that it is a suspected or probable case of SARS, BCDC will notify the Bureau of Epidemiology and Risk Assessment (BEHRA) and request that reporting facility fax copy of SARS Case Form immediately to 202-442-8060.

* BEHRA assumes responsibility for case investigation, assigns DOH SARS number and notifies Dr. Knuckles or Dr. Diallo at the Public Health Laboratory (PHL) at 202 727-8956 of the suspect or probable case. BEHRA request that the reporting facility begins to formulate line list of the patient's contacts and prior location within the facility.

* Types of specimen collected will be per "Guidelines for the Collection of Specimens from Potential Case of SARS", Centers for Disease Control (CDC) Matrix.

* Collecting facility labels specimens with two patient identifiers (name and date of birth), date and time of collection. A short history of patient's illness must accompany specimen (can be a copy of case report form). Facility contacts the DOH PHL at 202-727-8956 and request to speak directly with Dr. Diallo or Cleveland Weedon. Coordination of specimen transfer to the PHL will be done at this time. (Weekend and after-hours number is 202-727-6161)

* Specimen is packaged in usual fashion for transfer in a leak-proof container and marked with biohazard labeling.

* The PHL will not accept specimens without having prior contact from the sending facility and that facility notification of BEHRA.

* SARS testing is to be done by the DOH PHL, if positive the specimen is confirmed and sent to CDC for further confirmation as required by the CDC SARS Laboratory protocol. A CDC SARS identification number will be obtained by the PHL when specimen is prepared for shipment to CDC.

* The PHL will submit results to BEHRA and a copy to the submitting facility. Upon receipt, BEHRA will forward copies to BCDC

^top

 


CDC Issues SARS Advisory

On April 22, 2004, the Centers for Disease Control and Prevention issued the following advisory in response to a new possible case of Severe Acute Respiratory Syndrome (SARS) case in Beijing, China:

In light of this development, CDC is recommending that U.S. physicians maintain a greater index of suspicion for SARS in patients who 1) require hospitalization for radiographically confirmed pneumonia or acute respiratory distress syndrome (ARDS) AND 2) who have a history of travel to mainland China (or close contact with an ill person with a history of recent travel to mainland China) in the 10 days before onset of symptoms. When such patients are identified, they should be considered at high risk for SARS-CoV infection and the following actions should be taken:

* Patients should immediately be placed in appropriate isolation precautions for SARS (i.e., contact and airborne precautions along with eye protection).

* Patients should promptly be reported to the state or local health department.

* Patients should promptly be tested for evidence of SARS-CoV infection as part of the diagnostic evaluation.

* The health department should identify, evaluate, and monitor relevant contacts of the patient, as indicated. In particular, the health status of household contacts or persons who provided care to symptomatic patients should be assessed.

Health care providers are reminded to obtain a travel history for patients presenting with acute respiratory illness. In addition, this new case of possible SARS provides a reminder to all healthcare settings, especially physician offices, outpatient clinics, and emergency departments, of the importance of implementing infection control precautions at the point of first contact with patients who have symptoms of a respiratory infection. These include respiratory hygiene/cough etiquette, hand hygiene, and droplet precautions (i.e., masks for close patient contact). 

The reported new possible case of SARS in China represents an evolving situation, and CDC will distribute updates as additional information is learned. For more about SARS and the current U.S. SARS control guidelines, go to the CDC SARS web site:  http://www.cdc.gov/ncidod/sars

 

^top

 


Physicians Required to Report Lead Levels to DOH.

Daniel Lucey, MD, MPH, the city's interim chief medical officer, had no choice but to hit the floor running when he assumed office earlier this year thanks to the growing crisis of high lead levels in the District's water supply.

As part of his response to the crisis, Dr. Lucey reminded health care professionals of their responsibility under the law to report normal and abnormal serum lead levels to the DC Department of Health's (DOH) Childhood Lead Poisoning Prevention Program. The results should be faxed to DOH at 202-535-1398. This activity was mandated by the DC Childhood Lead Poisoning Screening and Reporting Act (Title XX of the Fiscal Year 2003 Budget Support Act of 2002).

Also, in late February Dr. Lucey issued letters to thousands of DC residents whose water supplies were thought to contain elevated lead levels. The letters offered recommendations on the use of unfiltered water and emphasized that those in three at-risk groups-pregnant women, women who are nursing, and young children-should use only filtered water. The letters and subsequent notices from the DOH also provided information on free screening facilities.

As this issue moves forward, members are encouraged to access the DC DOH web site for current information:
http://www.dchealth.dc.gov/information/fact_sheets/lead.shtm

^top

 


DOH Offers Advice on Lead Levels in DC Homes. 

On February 26, 2004, the DC Department of Health sent a letter to approximately 23,000 households in the District that are suspected of having an underground lead service pipe that brings drinking water into their residences. In the letter, the city's Interim Chief Medical Officer, Daniel Lucey, MD, offers advice for all occupants of residences that have lead service pipes, as well as specific advice for all children under the age of six years and women who are pregnant and living in these residences.

Click here to access the letter

Note: The letter is in PDF format. You will need Acrobat Reader to access it. 

If you don't have Acrobat Reader on your computer, click here to download it free of charge

^top

 


Initial Tests of Senate Office Indicate Powder is Ricin; CDC Fact Sheet on Ricin Available. 

Initial tests indicate that powder found in the office of Senate Majority Leader Bill Frist on Monday, February 2, 2004 was the lethal poison ricin.  The Medical Society encourages physicians and other clinicians to review facts about ricin, including signs and symptoms of ricin exposure (inhalation and ingestion). To access the CDC's Fact Sheet on ricin, go to:
http://www.bt.cdc.gov/agent/ricin/facts.asp#topofpage
 

^top

 

Keep Your Doctor in D.C.

MSDC is working with its allies and the City Council to protect the health of District residents by passing medical liability reform.

Learn More>